RxDoctor Payments Data

Marc Adelsheimer, MD

Physical Medicine and Rehabilitation · Pittsburgh, PANPI 1528066180

Payments from drug & device makers

$677in general payments, 2019–2025

Across 30 payments — averaging $22.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$299
  • AbbVie$96
  • Pfizer$71
  • MDD US Operations, LLC$61
  • Relievant Medsystems, Inc.$31
  • Nevro Corp.$30
  • plus $89 from 5 others

What the payments were for

  • Food & beverage$677100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott9$299
AbbVie(2 entities)6$96
Pfizer4$71
MDD US Operations, LLC4$61
Relievant Medsystems, Inc.1$31
Nevro Corp.1$30
Bioventus LLC1$22
Electronic Waveform Lab, Inc.1$21
Si-bone, Inc.1$18
Amgen1$17
Teva Pharmaceuticals USA, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$677 in reported general payments places this provider in the 70th percentile of 550 physical medicine and rehabilitation providers in Pennsylvania.

See all physical medicine and rehabilitation providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$13,803
Medicare patients
56
Services billed
125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin12$904
Gabapentin48$716
Methocarbamol22$353
Duloxetine Hcl13$96
Oxycodone Hcl11$28

Paid to pharmacies, not to this prescriber.

Other physical medicine and rehabilitation in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →